nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ABCB1—peripheral nervous system neoplasm	0.382	1	CbGaD
Maprotiline—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0437	0.165	CbGbCtD
Maprotiline—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0382	0.144	CbGbCtD
Maprotiline—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0382	0.144	CbGbCtD
Maprotiline—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.035	0.132	CbGbCtD
Maprotiline—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0265	0.1	CbGbCtD
Maprotiline—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0171	0.0645	CbGbCtD
Maprotiline—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0163	0.0616	CbGbCtD
Maprotiline—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0152	0.0574	CbGbCtD
Maprotiline—ABCB1—Etoposide—peripheral nervous system neoplasm	0.015	0.0564	CbGbCtD
Maprotiline—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0102	0.0385	CbGbCtD
Maprotiline—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00961	0.0363	CbGbCtD
Maprotiline—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00855	0.142	CbGeAlD
Maprotiline—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00469	0.0781	CbGeAlD
Maprotiline—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00357	0.0595	CbGeAlD
Maprotiline—HTR7—pons—peripheral nervous system neoplasm	0.00353	0.0588	CbGeAlD
Maprotiline—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00313	0.0521	CbGeAlD
Maprotiline—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00292	0.0487	CbGeAlD
Maprotiline—SLC6A3—nerve—peripheral nervous system neoplasm	0.00235	0.0392	CbGeAlD
Maprotiline—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00232	0.0387	CbGeAlD
Maprotiline—HTR2C—ganglion—peripheral nervous system neoplasm	0.00225	0.0374	CbGeAlD
Maprotiline—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00223	0.0371	CbGeAlD
Maprotiline—HTR2A—pons—peripheral nervous system neoplasm	0.0022	0.0367	CbGeAlD
Maprotiline—SLC6A2—nerve—peripheral nervous system neoplasm	0.0019	0.0316	CbGeAlD
Maprotiline—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00188	0.0313	CbGeAlD
Maprotiline—HTR7—nerve—peripheral nervous system neoplasm	0.00183	0.0305	CbGeAlD
Maprotiline—HTR7—ganglion—peripheral nervous system neoplasm	0.00181	0.0301	CbGeAlD
Maprotiline—DRD2—nerve—peripheral nervous system neoplasm	0.00173	0.0288	CbGeAlD
Maprotiline—DRD2—ganglion—peripheral nervous system neoplasm	0.00171	0.0285	CbGeAlD
Maprotiline—HTR2A—nerve—peripheral nervous system neoplasm	0.00114	0.019	CbGeAlD
Maprotiline—HTR2A—ganglion—peripheral nervous system neoplasm	0.00113	0.0188	CbGeAlD
Maprotiline—Sertraline—ABCB1—peripheral nervous system neoplasm	0.00109	0.524	CrCbGaD
Maprotiline—SLC6A3—brainstem—peripheral nervous system neoplasm	0.00101	0.0168	CbGeAlD
Maprotiline—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000983	0.0164	CbGeAlD
Maprotiline—HTR2C—brainstem—peripheral nervous system neoplasm	0.000977	0.0163	CbGeAlD
Maprotiline—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000815	0.0136	CbGeAlD
Maprotiline—HTR7—brainstem—peripheral nervous system neoplasm	0.000786	0.0131	CbGeAlD
Maprotiline—DRD2—brainstem—peripheral nervous system neoplasm	0.000743	0.0124	CbGeAlD
Maprotiline—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000663	0.011	CbGeAlD
Maprotiline—Protriptyline—ABCB1—peripheral nervous system neoplasm	0.000628	0.301	CrCbGaD
Maprotiline—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000498	0.0083	CbGeAlD
Maprotiline—HTR2A—brainstem—peripheral nervous system neoplasm	0.00049	0.00817	CbGeAlD
Maprotiline—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000446	0.00744	CbGeAlD
Maprotiline—HTR7—cerebellum—peripheral nervous system neoplasm	0.000387	0.00646	CbGeAlD
Maprotiline—DRD2—cerebellum—peripheral nervous system neoplasm	0.000366	0.0061	CbGeAlD
Maprotiline—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000363	0.00605	CbGeAlD
Maprotiline—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000242	0.00403	CbGeAlD
Maprotiline—Rash—Tretinoin—peripheral nervous system neoplasm	0.000229	0.000903	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000229	0.000903	CcSEcCtD
Maprotiline—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000229	0.000903	CcSEcCtD
Maprotiline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000229	0.000903	CcSEcCtD
Maprotiline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000229	0.000903	CcSEcCtD
Maprotiline—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000229	0.000902	CcSEcCtD
Maprotiline—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000228	0.0009	CcSEcCtD
Maprotiline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000228	0.000899	CcSEcCtD
Maprotiline—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000899	CcSEcCtD
Maprotiline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000227	0.000898	CcSEcCtD
Maprotiline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.000898	CcSEcCtD
Maprotiline—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000227	0.000897	CcSEcCtD
Maprotiline—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000227	0.000895	CcSEcCtD
Maprotiline—Constipation—Vincristine—peripheral nervous system neoplasm	0.000227	0.000895	CcSEcCtD
Maprotiline—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000895	CcSEcCtD
Maprotiline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000894	CcSEcCtD
Maprotiline—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000893	CcSEcCtD
Maprotiline—Rash—Melphalan—peripheral nervous system neoplasm	0.000226	0.000892	CcSEcCtD
Maprotiline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000226	0.000891	CcSEcCtD
Maprotiline—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.000888	CcSEcCtD
Maprotiline—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000883	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000222	0.000878	CcSEcCtD
Maprotiline—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000874	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000871	CcSEcCtD
Maprotiline—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.00022	0.00367	CbGeAlD
Maprotiline—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000219	0.000865	CcSEcCtD
Maprotiline—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.000863	CcSEcCtD
Maprotiline—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000858	CcSEcCtD
Maprotiline—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000858	CcSEcCtD
Maprotiline—Nausea—Topotecan—peripheral nervous system neoplasm	0.000217	0.000858	CcSEcCtD
Maprotiline—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000217	0.000856	CcSEcCtD
Maprotiline—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000217	0.000855	CcSEcCtD
Maprotiline—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000853	CcSEcCtD
Maprotiline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000216	0.000851	CcSEcCtD
Maprotiline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000216	0.000851	CcSEcCtD
Maprotiline—Infection—Etoposide—peripheral nervous system neoplasm	0.000213	0.000842	CcSEcCtD
Maprotiline—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000841	CcSEcCtD
Maprotiline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.00084	CcSEcCtD
Maprotiline—Nausea—Melphalan—peripheral nervous system neoplasm	0.000213	0.00084	CcSEcCtD
Maprotiline—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000836	CcSEcCtD
Maprotiline—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00021	0.000831	CcSEcCtD
Maprotiline—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00021	0.00083	CcSEcCtD
Maprotiline—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00021	0.000827	CcSEcCtD
Maprotiline—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000827	CcSEcCtD
Maprotiline—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00021	0.000827	CcSEcCtD
Maprotiline—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00021	0.000827	CcSEcCtD
Maprotiline—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000826	CcSEcCtD
Maprotiline—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000209	0.000823	CcSEcCtD
Maprotiline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000208	0.000819	CcSEcCtD
Maprotiline—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000817	CcSEcCtD
Maprotiline—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000808	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000806	CcSEcCtD
Maprotiline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.000801	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000202	0.000799	CcSEcCtD
Maprotiline—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000794	CcSEcCtD
Maprotiline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000201	0.000792	CcSEcCtD
Maprotiline—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000789	CcSEcCtD
Maprotiline—Desipramine—ABCB1—peripheral nervous system neoplasm	0.000198	0.0949	CrCbGaD
Maprotiline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000779	CcSEcCtD
Maprotiline—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000773	CcSEcCtD
Maprotiline—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000772	CcSEcCtD
Maprotiline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.000768	CcSEcCtD
Maprotiline—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000765	CcSEcCtD
Maprotiline—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000763	CcSEcCtD
Maprotiline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000193	0.000762	CcSEcCtD
Maprotiline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000193	0.000761	CcSEcCtD
Maprotiline—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00076	CcSEcCtD
Maprotiline—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000756	CcSEcCtD
Maprotiline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000191	0.000754	CcSEcCtD
Maprotiline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00019	0.000751	CcSEcCtD
Maprotiline—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000745	CcSEcCtD
Maprotiline—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000745	CcSEcCtD
Maprotiline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000745	CcSEcCtD
Maprotiline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000189	0.000745	CcSEcCtD
Maprotiline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.000743	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000739	CcSEcCtD
Maprotiline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.000738	CcSEcCtD
Maprotiline—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000734	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000185	0.000732	CcSEcCtD
Maprotiline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000731	CcSEcCtD
Maprotiline—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000185	0.000731	CcSEcCtD
Maprotiline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00073	CcSEcCtD
Maprotiline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000726	CcSEcCtD
Maprotiline—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000726	CcSEcCtD
Maprotiline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000184	0.000725	CcSEcCtD
Maprotiline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000718	CcSEcCtD
Maprotiline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000181	0.000716	CcSEcCtD
Maprotiline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000714	CcSEcCtD
Maprotiline—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000706	CcSEcCtD
Maprotiline—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000705	CcSEcCtD
Maprotiline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000704	CcSEcCtD
Maprotiline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000699	CcSEcCtD
Maprotiline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000177	0.000699	CcSEcCtD
Maprotiline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.000696	CcSEcCtD
Maprotiline—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000695	CcSEcCtD
Maprotiline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000176	0.000693	CcSEcCtD
Maprotiline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000175	0.000692	CcSEcCtD
Maprotiline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.00069	CcSEcCtD
Maprotiline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000689	CcSEcCtD
Maprotiline—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000689	CcSEcCtD
Maprotiline—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000689	CcSEcCtD
Maprotiline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000685	CcSEcCtD
Maprotiline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000684	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000683	CcSEcCtD
Maprotiline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00068	CcSEcCtD
Maprotiline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000676	CcSEcCtD
Maprotiline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000171	0.000673	CcSEcCtD
Maprotiline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000672	CcSEcCtD
Maprotiline—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000672	CcSEcCtD
Maprotiline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00017	0.00067	CcSEcCtD
Maprotiline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00017	0.00067	CcSEcCtD
Maprotiline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000669	CcSEcCtD
Maprotiline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000665	CcSEcCtD
Maprotiline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000169	0.000665	CcSEcCtD
Maprotiline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000664	CcSEcCtD
Maprotiline—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000168	0.0805	CrCbGaD
Maprotiline—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00066	CcSEcCtD
Maprotiline—Rash—Vincristine—peripheral nervous system neoplasm	0.000167	0.00066	CcSEcCtD
Maprotiline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000167	0.000659	CcSEcCtD
Maprotiline—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000656	CcSEcCtD
Maprotiline—Headache—Vincristine—peripheral nervous system neoplasm	0.000166	0.000656	CcSEcCtD
Maprotiline—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000652	CcSEcCtD
Maprotiline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000645	CcSEcCtD
Maprotiline—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000643	CcSEcCtD
Maprotiline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000633	CcSEcCtD
Maprotiline—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000632	CcSEcCtD
Maprotiline—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000625	CcSEcCtD
Maprotiline—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000158	0.00264	CbGeAlD
Maprotiline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000624	CcSEcCtD
Maprotiline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000157	0.000622	CcSEcCtD
Maprotiline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000621	CcSEcCtD
Maprotiline—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000621	CcSEcCtD
Maprotiline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000619	CcSEcCtD
Maprotiline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000616	CcSEcCtD
Maprotiline—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000611	CcSEcCtD
Maprotiline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000154	0.000608	CcSEcCtD
Maprotiline—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000607	CcSEcCtD
Maprotiline—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000607	CcSEcCtD
Maprotiline—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000603	CcSEcCtD
Maprotiline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000152	0.0006	CcSEcCtD
Maprotiline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000597	CcSEcCtD
Maprotiline—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000591	CcSEcCtD
Maprotiline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000588	CcSEcCtD
Maprotiline—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000585	CcSEcCtD
Maprotiline—Rash—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000583	CcSEcCtD
Maprotiline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000583	CcSEcCtD
Maprotiline—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000582	CcSEcCtD
Maprotiline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000147	0.00058	CcSEcCtD
Maprotiline—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000578	CcSEcCtD
Maprotiline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000577	CcSEcCtD
Maprotiline—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000574	CcSEcCtD
Maprotiline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000574	CcSEcCtD
Maprotiline—Tension—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000571	CcSEcCtD
Maprotiline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00057	CcSEcCtD
Maprotiline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000565	CcSEcCtD
Maprotiline—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000561	CcSEcCtD
Maprotiline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000142	0.000561	CcSEcCtD
Maprotiline—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000558	CcSEcCtD
Maprotiline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000553	CcSEcCtD
Maprotiline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000139	0.00055	CcSEcCtD
Maprotiline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000549	CcSEcCtD
Maprotiline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000547	CcSEcCtD
Maprotiline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000137	0.000539	CcSEcCtD
Maprotiline—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000539	CcSEcCtD
Maprotiline—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000535	CcSEcCtD
Maprotiline—Rash—Etoposide—peripheral nervous system neoplasm	0.000135	0.000534	CcSEcCtD
Maprotiline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000135	0.000534	CcSEcCtD
Maprotiline—Headache—Etoposide—peripheral nervous system neoplasm	0.000135	0.000531	CcSEcCtD
Maprotiline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000529	CcSEcCtD
Maprotiline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000528	CcSEcCtD
Maprotiline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000523	CcSEcCtD
Maprotiline—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000522	CcSEcCtD
Maprotiline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000521	CcSEcCtD
Maprotiline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000515	CcSEcCtD
Maprotiline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000512	CcSEcCtD
Maprotiline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000508	CcSEcCtD
Maprotiline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000504	CcSEcCtD
Maprotiline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000128	0.000504	CcSEcCtD
Maprotiline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000503	CcSEcCtD
Maprotiline—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000495	CcSEcCtD
Maprotiline—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000494	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000492	CcSEcCtD
Maprotiline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000485	CcSEcCtD
Maprotiline—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000483	CcSEcCtD
Maprotiline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000482	CcSEcCtD
Maprotiline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000479	CcSEcCtD
Maprotiline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000476	CcSEcCtD
Maprotiline—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000475	CcSEcCtD
Maprotiline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000473	CcSEcCtD
Maprotiline—Infection—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000472	CcSEcCtD
Maprotiline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000467	CcSEcCtD
Maprotiline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000467	CcSEcCtD
Maprotiline—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000466	CcSEcCtD
Maprotiline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000465	CcSEcCtD
Maprotiline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000465	CcSEcCtD
Maprotiline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000464	CcSEcCtD
Maprotiline—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000462	CcSEcCtD
Maprotiline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000459	CcSEcCtD
Maprotiline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000457	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000455	CcSEcCtD
Maprotiline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000449	CcSEcCtD
Maprotiline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000444	CcSEcCtD
Maprotiline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000443	CcSEcCtD
Maprotiline—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00044	CcSEcCtD
Maprotiline—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000437	CcSEcCtD
Maprotiline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000433	CcSEcCtD
Maprotiline—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000431	CcSEcCtD
Maprotiline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00043	CcSEcCtD
Maprotiline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00043	CcSEcCtD
Maprotiline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000429	CcSEcCtD
Maprotiline—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000427	CcSEcCtD
Maprotiline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000427	CcSEcCtD
Maprotiline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000425	CcSEcCtD
Maprotiline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000422	CcSEcCtD
Maprotiline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000418	CcSEcCtD
Maprotiline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000411	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.00041	CcSEcCtD
Maprotiline—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000104	0.00041	CcSEcCtD
Maprotiline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000406	CcSEcCtD
Maprotiline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000398	CcSEcCtD
Maprotiline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000395	CcSEcCtD
Maprotiline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.000392	CcSEcCtD
Maprotiline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000391	CcSEcCtD
Maprotiline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000389	CcSEcCtD
Maprotiline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000387	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.00038	CcSEcCtD
Maprotiline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.000379	CcSEcCtD
Maprotiline—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000377	CcSEcCtD
Maprotiline—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000376	CcSEcCtD
Maprotiline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000376	CcSEcCtD
Maprotiline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000376	CcSEcCtD
Maprotiline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.000362	CcSEcCtD
Maprotiline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.00036	CcSEcCtD
Maprotiline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.000349	CcSEcCtD
Maprotiline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000348	CcSEcCtD
Maprotiline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000348	CcSEcCtD
Maprotiline—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000341	CcSEcCtD
Maprotiline—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000336	CcSEcCtD
Maprotiline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000325	CcSEcCtD
Maprotiline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000315	CcSEcCtD
Maprotiline—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000314	CcSEcCtD
Maprotiline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000311	CcSEcCtD
Maprotiline—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000302	CcSEcCtD
Maprotiline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000301	CcSEcCtD
Maprotiline—Rash—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.0003	CcSEcCtD
Maprotiline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000299	CcSEcCtD
Maprotiline—Headache—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000298	CcSEcCtD
Maprotiline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000291	CcSEcCtD
Maprotiline—Nausea—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.000282	CcSEcCtD
Maprotiline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.00028	CcSEcCtD
Maprotiline—Rash—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000277	CcSEcCtD
Maprotiline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000277	CcSEcCtD
Maprotiline—Headache—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000275	CcSEcCtD
Maprotiline—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000261	CcSEcCtD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.26e-05	0.000608	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.25e-05	0.000604	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.24e-05	0.000602	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.21e-05	0.000594	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.21e-05	0.000593	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.2e-05	0.000591	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.2e-05	0.000591	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.19e-05	0.000587	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.17e-05	0.000583	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.17e-05	0.000582	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.16e-05	0.000581	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.16e-05	0.00058	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.16e-05	0.00058	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.15e-05	0.000578	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.15e-05	0.000578	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.15e-05	0.000577	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.14e-05	0.000576	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.13e-05	0.000573	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.12e-05	0.000571	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.12e-05	0.000571	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.12e-05	0.000569	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.09e-05	0.000562	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.08e-05	0.000561	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.08e-05	0.000559	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.07e-05	0.000557	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.06e-05	0.000554	CbGpPWpGaD
Maprotiline—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	2.06e-05	0.000554	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.06e-05	0.000553	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.05e-05	0.000552	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	2.05e-05	0.000551	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.03e-05	0.000545	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	2.02e-05	0.000544	CbGpPWpGaD
Maprotiline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2e-05	0.000539	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2e-05	0.000538	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2e-05	0.000538	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2e-05	0.000536	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.99e-05	0.000536	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.99e-05	0.000535	CbGpPWpGaD
Maprotiline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.99e-05	0.000534	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.98e-05	0.000534	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.98e-05	0.000533	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.98e-05	0.000532	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.97e-05	0.00053	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.96e-05	0.000527	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.95e-05	0.000523	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.94e-05	0.000521	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.93e-05	0.000518	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.91e-05	0.000513	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.9e-05	0.00051	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.89e-05	0.000509	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.89e-05	0.000508	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.89e-05	0.000507	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.88e-05	0.000506	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.87e-05	0.000502	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.86e-05	0.000501	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000501	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.81e-05	0.000487	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.8e-05	0.000484	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.8e-05	0.000484	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.77e-05	0.000475	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.75e-05	0.000471	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	1.73e-05	0.000466	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.73e-05	0.000464	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.73e-05	0.000464	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.71e-05	0.000461	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.65e-05	0.000445	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.65e-05	0.000444	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.64e-05	0.000442	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	1.63e-05	0.000438	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.58e-05	0.000426	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.58e-05	0.000425	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.52e-05	0.000409	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.52e-05	0.000408	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.5e-05	0.000403	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.5e-05	0.000402	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.49e-05	0.000401	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.49e-05	0.000399	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.48e-05	0.000397	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.47e-05	0.000396	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.45e-05	0.00039	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.41e-05	0.000378	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.34e-05	0.00036	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	1.33e-05	0.000357	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000355	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000354	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.31e-05	0.000353	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.31e-05	0.000351	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.3e-05	0.000351	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.3e-05	0.00035	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.3e-05	0.00035	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.29e-05	0.000348	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000347	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.28e-05	0.000345	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.28e-05	0.000344	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.27e-05	0.000343	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.27e-05	0.000342	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.26e-05	0.000338	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.24e-05	0.000334	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.24e-05	0.000333	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	0.000329	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.22e-05	0.000329	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.22e-05	0.000328	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.22e-05	0.000328	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000327	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.22e-05	0.000327	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.21e-05	0.000326	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.2e-05	0.000322	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.17e-05	0.000314	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.15e-05	0.000309	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.14e-05	0.000306	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000301	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000301	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000301	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.11e-05	0.0003	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000299	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.1e-05	0.000296	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.1e-05	0.000296	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.1e-05	0.000295	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.000282	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.04e-05	0.000279	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000278	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.03e-05	0.000278	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.88e-06	0.000266	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	9.73e-06	0.000262	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.62e-06	0.000259	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.13e-06	0.000245	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.08e-06	0.000244	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.06e-06	0.000244	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.97e-06	0.000241	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.81e-06	0.000237	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	8.77e-06	0.000236	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.73e-06	0.000235	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.7e-06	0.000234	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.56e-06	0.00023	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.43e-06	0.000227	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.37e-06	0.000225	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.32e-06	0.000224	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	8.25e-06	0.000222	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.24e-06	0.000222	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.19e-06	0.00022	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.06e-06	0.000217	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8e-06	0.000215	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.97e-06	0.000214	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	7.95e-06	0.000214	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.93e-06	0.000213	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.92e-06	0.000213	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.91e-06	0.000213	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.89e-06	0.000212	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.89e-06	0.000212	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.86e-06	0.000211	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.8e-06	0.00021	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.79e-06	0.000209	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.78e-06	0.000209	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.77e-06	0.000209	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.75e-06	0.000208	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.72e-06	0.000208	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.65e-06	0.000206	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.55e-06	0.000203	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.32e-06	0.000197	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.23e-06	0.000195	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.09e-06	0.000191	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.91e-06	0.000186	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.81e-06	0.000183	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.73e-06	0.000181	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.68e-06	0.00018	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.62e-06	0.000178	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.61e-06	0.000178	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.49e-06	0.000175	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.44e-06	0.000173	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.43e-06	0.000173	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.26e-06	0.000168	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.16e-06	0.000166	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.16e-06	0.000166	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.14e-06	0.000165	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.12e-06	0.000165	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.1e-06	0.000164	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.04e-06	0.000163	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.9e-06	0.000159	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.89e-06	0.000158	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.8e-06	0.000156	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.79e-06	0.000156	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.77e-06	0.000155	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.75e-06	0.000155	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.73e-06	0.000154	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.7e-06	0.000153	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.68e-06	0.000153	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.64e-06	0.000152	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.63e-06	0.000151	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.61e-06	0.000151	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.6e-06	0.00015	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.59e-06	0.00015	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.59e-06	0.00015	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.58e-06	0.00015	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.56e-06	0.000149	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.54e-06	0.000149	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.54e-06	0.000149	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.49e-06	0.000148	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.39e-06	0.000145	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.35e-06	0.000144	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.29e-06	0.000142	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.21e-06	0.00014	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.12e-06	0.000138	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.11e-06	0.000137	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.09e-06	0.000137	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.08e-06	0.000137	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.06e-06	0.000136	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.05e-06	0.000136	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.03e-06	0.000135	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.02e-06	0.000135	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.84e-06	0.00013	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.76e-06	0.000128	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.73e-06	0.000127	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.68e-06	0.000126	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.67e-06	0.000126	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.66e-06	0.000125	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.64e-06	0.000125	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.6e-06	0.000124	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.46e-06	0.00012	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.43e-06	0.000119	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.36e-06	0.000117	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.35e-06	0.000117	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.34e-06	0.000117	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.33e-06	0.000116	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.28e-06	0.000115	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.27e-06	0.000115	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.13e-06	0.000111	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.95e-06	0.000106	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.64e-06	9.79e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	3.59e-06	9.64e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.58e-06	9.63e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.58e-06	9.61e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.56e-06	9.58e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.55e-06	9.55e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.52e-06	9.46e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.48e-06	9.37e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.48e-06	9.36e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.43e-06	9.21e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.42e-06	9.19e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.41e-06	9.16e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.4e-06	9.13e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.36e-06	9.05e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.07e-06	8.27e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.03e-06	8.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.02e-06	8.12e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.01e-06	8.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3e-06	8.06e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.97e-06	7.99e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.28e-06	6.12e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.14e-06	5.77e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-06	4.89e-05	CbGpPWpGaD
